Cytomedix Inc (OTCBB - OTCQX US:CMXI)
| 0.45 Data as of 3:46pm ET |  -0.04 / -8.16%Today’s Change | 0.43 Today|||52-Week Range 1.95 | -37.50% Year-to-Date |
Latest CMXI News | Press Releases
No recent news for Cytomedix Inc.
Today’s Trading
| Previous close | 0.49 |
| Today’s open | 0.49 |
| Day’s range | 0.45 - 0.49 |
| Volume | 43,613 |
| Average volume (3 months) | 106,164 |
| Market cap | $51.2M |
| Dividend yield | -- |
Data as of 3:46pm ET, 06/18/2013
Growth & Valuation
| Earnings growth (last year) | -200.00% |
| Earnings growth (this year) | +66.67% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +45.77% |
| P/E ratio | NM |
| Price/Sales | 5.58 |
| Price/Book | 1.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ORMPOramed Pharmaceutica... | -0.55 | -7.91% |
| NBYNovaBay Pharmaceutic... | +0.01 | +0.75% |
| --DelMar Pharmaceutica... | -0.20 | -9.09% |
| MNOVMediciNova Inc | +0.07 | +2.80% |
Data as of 4:00pm ET, 06/18/2013
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $10.6M |
| Annual profit (last year) | -$19.8M |
| Net profit margin | -187.41% |
Profile
Sector Health Technology |
Industry Biotechnology |
Executive Chairman & Head-Investor Relations David Emerson Jorden, MBA, CPA |
Chief Executive Officer & Director Martin P. Rosendale |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
